Protagonist Therapeutics
PTGX
#3636
Rank
A$4.26 B
Marketcap
$69.56
Share price
-0.89%
Change (1 day)
75.85%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2023 (TTM): -$4.02

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is -$4.19. In 2022 the company made an earnings per share (EPS) of -$4.07 an increase over its 2021 EPS that were of -$4.23.

EPS history for Protagonist Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.02-1.17%
2022-$4.07-3.7%
2021-$4.2335%
2020-$3.13-33.33%
2019-$4.6974.42%
2018-$2.69-20.74%
2017-$3.40-45.64%
2016-$6.2557.3%
2015-$3.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.41-18.66%๐Ÿ‡บ๐Ÿ‡ธ USA